Related references
Note: Only part of the references are listed.Direct Ubiquitination of β-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1
Yoana N. Dimitrova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MYC in Oncogenesis and as a Target for Cancer Therapies
Ami Albihn et al.
ADVANCES IN CANCER RESEARCH, VOL 107 (2010)
Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma
Jie Hu et al.
CANCER RESEARCH (2009)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C. Coulouarn et al.
ONCOGENE (2009)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease
Paola Bovolenta et al.
JOURNAL OF CELL SCIENCE (2008)
Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL
Vipul C. Chitalia et al.
NATURE CELL BIOLOGY (2008)
A Cryptic Frizzled Module in Cell Surface Collagen 18 Inhibits Wnt/β-Catenin Signaling
Delphine Quelard et al.
PLOS ONE (2008)
Frizzled-7 as a potential therapeutic target in colorectal cancer
Koji Ueno et al.
NEOPLASIA (2008)
The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo
Venita I. DeAlmeida et al.
CANCER RESEARCH (2007)
The many ways of Wnt in cancer
Paul Polakis
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Wnts as ligands: processing, secretion and reception
A. J. Mikels et al.
ONCOGENE (2006)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Adenomatous polyposis coli (APC) differentially regulates β-catenin phosphorylation and ubiquitination in colon cancer cells
Jun Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations
BA He et al.
ONCOGENE (2005)
The links between axin and carcinogenesis
S Salahshor et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Receptor and secreted targets of Wnt-I/β-catenin signalling in mouse mammary epithelial cells -: art. no. 3
PA Kenny et al.
BMC CANCER (2005)
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
H Suzuki et al.
NATURE GENETICS (2004)
The Wnt antagonist sFRP1 in colorectal tumorigenesis
GM Caldwell et al.
CANCER RESEARCH (2004)
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer
T Takeuchi et al.
CLINICAL CANCER RESEARCH (2004)
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration
OJ Sansom et al.
GENES & DEVELOPMENT (2004)
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
A Bafico et al.
CANCER CELL (2004)
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation
L Topol et al.
JOURNAL OF CELL BIOLOGY (2003)
Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif
H Elamaa et al.
MATRIX BIOLOGY (2003)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach
N Ahmed et al.
PROTEOMICS (2003)
Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116:: preservation of its malignant phenotype
S Sekine et al.
ONCOGENE (2002)
Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma
RF Holcombe et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2002)
Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation
TA Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cloning of three variants of type XVIII collagen and their expression patterns during Xenopus laevis development
H Elamaa et al.
MECHANISMS OF DEVELOPMENT (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains
CE Dann et al.
NATURE (2001)
Expression of Wnt genes in human colon cancers
A Dimitriadis et al.
CANCER LETTERS (2001)
Tumor hepatocytes and basement membrane-producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers
O Musso et al.
HEPATOLOGY (2001)
Share Paper
